Mobile ordering technology for hospital employees just got a major tech upgrade. Photo courtesy of Rivalry Tech

Houston-based Rivalry Tech announced that it has partnered up with Canadian RoboEatz to bring hospital employees on-demand meals 24/7.

RoboEatz is known for its autonomous robotic kitchen system, which prepares high-quality dishes efficiently and consistently for health care organizations, businesses, higher education institutions and quick-service restaurants.

Rivalry Tech will couple RoboEatz's system with its user interface, known as myEATZ, that's currently in use at several Houston Methodist Hospitals, the TMC Innovation Factory, and in resorts, hospitals, office buildings, and more, according to the company's website.

"At Rivalry Tech, we're dedicated to pushing our boundaries into cutting-edge technologies with innovative partners like RoboEatz," Aaron Knape, CEO of Rivalry Tech, says in a statement. "Partnering with RoboEatz allows us to take this commitment a step further by providing an interface that gives users complete control over their dining choices and preferences."

Rivalry Tech originally founded myEATZ as an in-stadium ordering app in 2018, then known as sEATz. The company rebranded and introduced myEATz in 2022 and launched a new app about a year ago.

The company raised $3.5 million in funding to expand into the health care space in 2022 and initially rolled out at Houston Methodist The Woodlands Hospital, Houston Methodist West Hospital, Houston Methodist Clear Lake Hospital, Houston Methodist Continuing Care Hospital, and Houston Methodist Willowbrook Hospital last spring. According to Rivalry, its partner Aramark Healthcare+ has been important to the expansion of their technology within the health care sector.

"We believe this partnership marks a pivotal moment in the evolution of dining technology," Janis Poruks, CTO and Co-Founder of RoboEatz, said in a statement. "By integrating Rivalry Tech's user interface with our automated robotic kitchen, we're transforming dining into an interactive and personalized experience. Our goal is to redefine convenience and quality in dining while reducing the need for full-time employees."

MyEATZ, then sEATz, was part of Softeq Development’s accelerator in 2022. Click here to see the latest Houston tech companies to join.
More Houston-area hospital workers now have access to this Houston startup's mobile ordering platform. Image courtesy of Rivalry Tech

Mobile ordering tech company expands to 5 Houston hospitals

hi, tech

More Houston hospital workers now have access to on-demand mobile ordering thanks to a Houston startup.

Houston-based Rivalry Tech has rolled out its its mobile ordering platform, myEATz, into five of Houston Methodist's hospital cafes. The hospital employees can now order food and beverages from the myEATz app or web platform.

The platform is now available at: Houston Methodist The Woodlands Hospital, Houston Methodist West Hospital, Houston Methodist Clear Lake Hospital, Houston Methodist Continuing Care Hospital, and Houston Methodist Willowbrook Hospital.

"Employee wellness is especially important in healthcare as worker shortages, combined with fatigue, continue to be a concern," says Aaron Knape, CEO and co-founder of Rivalry Tech, in a news release. "MyEATz offers more than just access to onsite food and beverage options, it encourages employees to utilize their meal breaks to recharge and make the most of their break."

The expansion aligns with Rivalry's partnership with Aramark Healthcare+, which operates all of the dining operations at Houston Methodist.

“We are thrilled to expand our partnership with Rivalry Tech to bring mobile ordering to five additional Aramark Healthcare+ Houston Methodist locations," says Dave Hanson, vice president of operations at Aramark Healthcare+, in the release. "Our continued investment in technology is a testament to our commitment to providing exceptional service and convenience to our healthcare caregivers. With Rivalry Tech's myEATz platform and our operational expertise, we are confident in our ability to enhance the overall dining experience for our guests.”

Founded in 2018 as sEATz, an in-stadium ordering app, Rivalry Tech rebranded and introduced the myEATz concept last year. Since then, the company rolled out its new app and raised $3.5 million in funding to expand its technology into the health care hospitality space.

A Houston startup is making mobile food ordering a whole lot easier within health care facilities. Photo by Jonas Leupe on Unsplash

Houston tech company launches app to upgrade mobile ordering

download now

A Houston tech company has launched its mobile ordering app, the company announced last week.

Rivalry Tech, which created sEATz, an in-seat food delivery platform for sports and entertainment venues, has launched myEATZ in the App Store and Google Play. The platform is designed for facilities with 24/7/365 dining needs, and the app's initial focus is on the health care industry.

Health care employees work long shifts and have to optimize their break time. With the myEATZ app, these workers can order ahead and skip the line at nearby eateries. For Rivalry Tech's co-founder and CEO, Aaron Knape, being able to provide this tool to health care workers is a personal win for him.

“Being married to a nurse, and living next door to the largest medical center in the world, I’ve seen the challenges faced by healthcare workers the past few years," he says in a news release. "To offset long hours and short breaks, the myEATz platform can truly give time back to healthcare workers by letting them skip the line.”

Outside of health care, myEATz has also identified opportunities within the hospitality industry. Last year, myEATz launched at Margaritaville Lake Conroe to allow guests to mobile order food and beverage directly to their pool chair. The expansion is in its second phase with plans to rollout into other hotels.

Originally founded as sEATz in 2018 by Knape, Marshall Law, and Craig Ceccanti, Rivalry Tech raised $3.5 million in November. The round was led by Houston-based Sightcast, with participation from Houston-based Softeq Venture Studio, Rice University’s Valhalla Investment Group, and more.

The myEATz app is available now. Image courtesy of Rivalry Tech

Here are the 10 Houston startups that closed venture capital investment in the fourth quarter of last year. Photo via Getty Images

10 Houston startups start 2023 with fresh venture capital funding

money moves

Houston startups saw a busy last quarter when it came to funding in 2022. From seed to series C, 10 Houston startups wrapped up the year with investment round closings.

In case you missed some of these headlines, InnovationMap has rounded up these 10 deals based on previous reporting. Scroll through to see which Houston startups are catching the eyes — and cashing the checks — of investors.

Houston-based virtual reality startup raises $3.2M in first outside capital round

VR training startup, HTX Labs, has raised funding from an outside investor for the first time. Courtesy of HTX Labs

HTX Labs, a Houston-based company that designs extended reality training for military and business purposes, announced last week that it has raised its first outside capital.

The company has received a $3.2 million investment from Cypress Growth Capital. Founded in 2017, HTX Labs — developer of the EMPACT Immersive Learning Platform — has been granted funding from the Department of Defense as well as grown its client base of commercial Enterprises. The platform uses virtual and extended reality that "enables organizations to rapidly create, deploy, measure, and sustain cost-effective, secure, and centralized immersive training programs, all within engaging, fully interactive virtual environments," per a news release.

“We have been looking to secure outside capital to accelerate the growth of our EMPACT platform and customer base but we hadn’t found the right partner who provided an investment vehicle that matched our needs,“ says HTX Labs CEO Scott Schneider in the release. “We found everything we were looking for in Cypress Growth Capital. They have a non-dilutive funding model that aligns with our capital expectations and have the level of experience that really makes this smart money." Read more.

Houston-based travel tech startup raises nearly $1M to continue expansion

A Houston company has raised additional funding as it grows its encrypted lodging booking platform. Photo via Gustavo Fring/Pexels

A travel booking technology company that's looking to alleviate some of the stresses of finding and making hotel reservations has raised additional seed funding.

Houston-based Pinktada has raised additional funding to the tune of $975,000. Ireland-based Selenean Capital contributed to the seed funding round, joining the company's previous investor True Global Ventures 4 Plus, which has invested $2 million to date. According to Crunchbase data, the latest investment brings the company's total to $3.9 million.

“Selenean Capital’s approach to partnership is identifying real world future needs and then working relentlessly to achieve those goals," says Davin Browne, Selenean’s CEO, in a news release. "Pinktada encapsulates this perfectly with a transformational approach to the hotel booking model built around a brilliant team. We look forward to the partnership and journey with them." Read more.

Houston microgrid tech company announces $150 investment

Houston-based VoltaGrid provides small-scale, self-contained microgrids that can operate independently of major power grids or in tandem with other microgrids. Photo via voltagrid.com

VoltaGrid, a Bellaire-based startup that specializes in distributed power generation via microgrids, has hauled in $150 million in equity funding.

Founded in 2020, VoltaGrid provides small-scale, self-contained microgrids that can operate independently of major power grids or in tandem with other microgrids. VoltaGrid’s product consists of natural gas engines, portable energy storage, natural gas processing and grid power connectivity.

Investors in the $150 million round include the Canada Pension Plan Investment Board (CPP Investments), Longbow Capital, Walter Ventures, and Pilot Company (operator of more than 800 retail and fueling locations in the U.S. and Canada). The $150 million round comes less than a year after VoltaGrid announced a $100 million round featuring the same investors.Read more.

Houston SaaS company raises $15M series B, announces latest release

Houston-based GoCo.io has raised fresh funding and launched the latest version of its platform. Courtesy of GoCo

A Houston startup that is optimizing human resource operations for small businesses has raised fresh funding from an Austin-based venture capital investor.

GoCo.io raised $15 million in September in a funding round led by ATX Venture Partners. Founded in 2015, the company has raised $27.5 million to date, including its $7 million series A in 2019.

The fresh funding will be used to continue expanding on the company's software services operations and upgrades to its product, which is is modernizing HR, benefits, and payroll.

“We believe that GoCo is the company best positioned to provide HR departments at SMBs with the most flexible employee management software,” says Chris Shonk, general partner at ATX Venture Partners, in a news release. “In a crowded marketplace, GoCo clearly rises to the top with its ease-of-use, flexibility and unparalleled customization. Read more.

Houston tech startup raises $3.5M following industry expansion

Rivalry Tech's co-founders — Marshall Law and Aaron Knape — share news of the company's latest round of investment. Photo courtesy of Rivalry Tech

A Houston-based company that optimizes mobile ordering for large venues has closed its latest round of funding.

Rivalry Tech, originally founded as sEATz and tackling mobile ordering in sports venues, has raised $3.5 million following expanding with a new product, myEATz, that targets the health care, leisure, and business industries. The round was led by Houston-based Sightcast, with participation from Houston-based Softeq Venture Studio, Rice University’s Valhalla Investment Group, and more.

“Sightcast Capital Partners looks to invest in strong, founder-led companies that bring a forward-thinking solution to everyday problems," says Neal Simpson, managing partner of Sightcast Capital Partners, in a news release. "In Rivalry Tech, we saw a team that recognized an opportunity to streamline the way in which food and beverage transactions occur in the healthcare, leisure, sports, and entertainment markets. Their two-sided approach of using technology as a tool to increase vendor profitability and also positively influence consumer experience is what immediately attracted us to this opportunity." Read more.

Houston unicorn chemicals company raises $200M series D

Solugen closed its series D funding round at $200 million. Photo via Getty Images

Houston-based Solugen has announced its latest round of investment to the tune of $200 million. The company, which reached unicorn status after its $357 million series C round last year, uses its patented Bioforge processes to produce "green" chemicals from bio-based feedstocks.

"Solugen is reimagining the chemistry of everyday life with enzymes found in nature. We make chemicals better, faster, cheaper, and without fossil fuels from right here in Houston, Texas. Whether you care about the climate, local competitiveness, or just plain old profits, we have good news: it's working," the company states in its news release. Read more.

Houston company closes $76M series C round to fuel its mission of reducing carbon emissions

Syzygy Plasmonics has raised a series C round of funding. Photo courtesy of Syzygy

A Houston-based company that is electrifying chemical manufacturing has closed its largest round of funding to date.

Syzygy Plasmonics closed a $76 million series C financing round led by New York-based Carbon Direct Capital. The round included participation from Aramco Ventures, Chevron Technology Ventures, LOTTE CHEMICAL, and Toyota Ventures. The company's existing investors joining the round included EVOK Innovations, The Engine, Equinor Ventures, Goose Capital, Horizons Ventures, Pan American Energy, and Sumitomo Corporation of Americas. According to a news release, Carbon Direct Capital will join Syzygy's board and serve as the series C director.

"We were very attracted to the multiple use cases for the Syzygy reactor and the lifetime-value of each Syzygy customer," says Jonathan Goldberg, Carbon Direct Capital's CEO, in the release. "Emissions from hydrogen production total more than 900 million metric tons of carbon dioxide per year. Syzygy's photocatalysis technology is a key solution to decarbonize hydrogen production as well as other critical industries." Read more.

Houston SaaS startup raises $6M seed

Houston-based SynMax has closed its first round of funding. Photo via Getty Images

A Houston-based satellite data analytics company is celebrating an oversubscribed round of recent funding.

SynMax announced this week that it closed its seed round at $6 million with an oversubscription of $2 million. The startup is providing geospatial intelligence software as a service to customers within the energy and maritime industries. The technology combines earth observation imagery and key data sources for predictive analytics and artificial intelligence.

The company reports that all of the investment came from SynMax customers. The round was led by Houston-based Skylar Capital, an investment management firm focused on the natural gas market. Read more.

Houston health tech startup secures $27M in financing

A Houston startup that created a remote monitoring and care platform has raised millions in financing. Image via michealthcare.com

A virtual health care and analytics provider startup has closed its latest round of funding for a total of $27 million in financing.

Medical Informatics Corp. closed a $17 million series B co-led by Maryland-based Catalio Capital Management and California-based Intel Capital. The financing also includes an additional $10 million in debt led by Catalio through Catalio’s structured equity strategy, according to a news release.

“We are excited to have had this round co-led by Catalio and Intel Capital," says Emma Fauss, CEO and co-founder of MIC, in the release. "Catalio brings significant financial and technical resources, while Intel Capital possesses strong operational and industry experience, and we look forward to continuing to leverage both firms’ expertise as we continue to scale.” Read more.

Houston sportstech platform raises $1.3M seed round

This Houston startup has fresh funding to build out its data intelligence platform. Photo via aim7.com

How many times have you forced yourself to do an arduous workout when you just weren’t feeling it? Despite what some trainers will tell you, you probably didn’t feel any better after. Sports scientist Dr. Erik Korem could have told you that, but more importantly, so could his creation, AIM7.

Marketed as “the fastest, easiest way to change your habits and improve your health,” Korem just raised a $1.3 million seed round that will bring his ambitious app to consumers in its beta form early next month.

The data intelligence platform would know that on a day that you’re stressed, that Peloton tabata ride might not be in your best interest. How? “The data from your Apple Watch or your Fitbit is just data. ‘I walked 7000 steps or I slept 8 hours,’” explains Korem. “We are the recommendation engine that makes this usable for you.” Read more.

This growing mobile ordering startup has rebranded to represent its growth. Photo courtesy of sEATz

Growing Houston sportstech company rebrands following platform expansion

the rivalry is on

The Houston startup that enabled in-seat food and beverage ordering at stadiums has grown over the past few years — and the company has entered into its new era with a rebrand.

Houston-based sEATz expanded this year to evolve its technology to enable optimized mobile ordering within hospitals. Launching that new platform, called myEATz, led to a need for a defined parent company to account for the growing company. Rivalry Technology will be run by the same sEATz and myEATz team.

“I always knew that sEATz would grow into something special," says Rivalry Tech CEO and Co-Founder Aaron Knape in a news release. "As we continue to expand and grow, our brand has also grown with it. With sEATz holding sway over Sports and Entertainment, and the myEATz platform making rapid inroads into healthcare, business dining and leisure, the Rivalry Tech branding will help pull it all together.”

The rebrand comes with a new logo, website, and social media accounts. Rivalry's chief of staff, Megan Fier, designed the new logo with sEATz's original design and colors in mind.

“Knowing how recognized the sEATz brand has become, I needed to design the Rivalry Tech logo to compliment that," she says in the release. "The dual arrows pointing together represent our two platform brands. The orange sEATz half shows where we started while the navy blue myEATz shows where we are going.”

The new website also showcases both brands with information for those interested in both platforms.

“Prior to our rebrand, we had two separate websites presenting as two separate companies," Fier says. "I wanted our website to be our go-to place for both sEATz and myEATz, to show that cohesion and showcase the depth of our offerings as Rivalry Tech. The new Rivalry Tech website shares our products, tells our story, and gives site visitors a place to connect to our team all in one website. Afterall, we are more than just mobile ordering.”

The name reflects the three sEATz co-founders' alma maters: Knape graduated from Texas A&M University, Marshall Law from the University of Texas, and Craig Ceccanti from Louisiana State University.

“An Aggie, a Longhorn, and an LSU Tiger walked into a bar," Knape explains, "and it was the only name on which we could agree.“

Founded in 2018, the company has raised two seed rounds — one in 2019 and another amid the pandemic in 2020. Following that funding, Knape previously told InnovationMap that he's focused on the company's growth.

"I tell the team that we're kind of coming out of stealth mode — I know we're not in a true stealth mode, but we haven't spent a lot of money on sales and marketing," Knape says on the Houston Innovators Podcast. "Now it's time to start putting that emphasis on who we are, that we're here, and we're ready to take over."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.